| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Pharmacy (Drs. Strassels and Sullivan), University of Washington, Seattle, WA; Kaiser Permanente Center for Health Research (Dr. Smith), Portland, OR; and Global Health Outcomes (Dr. Mahajan), Glaxo Wellcome Inc., Research Triangle Park, NC.
Correspondence to: Scott A. Strassels, PharmD, BCPS, Department of Pharmacy, University of Washington, Box 357630, Seattle, WA 98195; e-mail: scotts1{at}u.washington.edu
Study objectives: COPD affects millions of people in the United States. The purpose of this study was to describe the medical resource use and costs incurred by persons with COPD in the United States in 1987.
Design: Data for this study were derived from the 1987 National Medical Expenditure Survey. A societal perspective was adopted for this analysis.
Patients
or participants: All persons 
40 years old with resource use
or expenditures for chronic bronchitis, emphysema, or nonspecific
chronic airway obstruction were included in this study.
Results: Mean per-person direct medical expenditures among persons with COPD were $6,469 (1987 US dollars), about 25% of which was COPD related. Approximately 68% of direct medical expenditures in persons with COPD were for inpatient hospitalization.
Conclusions: COPD causes a large societal burden of illness that is expected to increase. This study provides a valuable foundation and historical measure against which to compare other estimates.
Key Words: COPD • cost of illness • economics • National Medical Expenditure Survey
This article has been cited by other articles:
|
|
 |
|
  K. Vijayasaratha and R. A. Stockley Reported and Unreported Exacerbations of COPD: Analysis by Diary Cards Chest, January 1, 2008; 133(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Cote, L. J. Dordelly, and B. R. Celli Impact of COPD Exacerbations on Patient-Centered Outcomes Chest, March 1, 2007; 131(3): 696 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. G. Halpin and M. Miravitlles Chronic Obstructive Pulmonary Disease: The Disease and Its Burden to Society Proceedings of the ATS, September 1, 2006; 3(7): 619 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B S Moffett, A L Parham, C D Caudilla, A R Mott, and K D Gurwitch Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies. Qual. Saf. Health Care, August 1, 2006; 15(4): 240 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dusser, M-L. Bravo, P. Iacono, and on behalf the MISTRAL study group The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur. Respir. J., March 1, 2006; 27(3): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Niewoehner, K. Rice, C. Cote, D. Paulson, J. A. D. Cooper Jr., L. Korducki, C. Cassino, and S. Kesten Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial Ann Intern Med, September 6, 2005; 143(5): 317 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Decramer, R Gosselink, M Rutten-Van Molken, J Buffels, O Van Schayck, P-A Gevenois, R Pellegrino, E Derom, and W De Backer Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004 Thorax, April 1, 2005; 60(4): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ho, D. Pacaud, M. D. Hill, C. Ross, L. Hamiwka, and J. K. Mah Diabetic ketoacidosis and pediatric stroke Can. Med. Assoc. J., February 1, 2005; 172(3): 327 - 328. [Full Text] [PDF]
|
|
|
|
|
|
C. Steurer-Stey, L. M. Bachmann, J. Steurer, and M. R. Tramer Oral Purified Bacterial Extracts in Chronic Bronchitis and COPD: Systematic Review Chest, November 1, 2004; 126(5): 1645 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Monninkhofe, P Van der valk, T Schermer, J Van der palen, C Van herwaarden, and G Zielhuis Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease Chronic Respiratory Disease, January 1, 2004; 1(1): 7 - 16. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Newall, C. Barnes, H. Savoia, J. Campbell, and P. Monagle Warfarin Therapy in Children Who Require Long-Term Total Parenteral Nutrition Pediatrics, November 1, 2003; 112(5): e386 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Mullins, J. Wang, and J. K. Stoller Major Components of the Direct Medical Costs of {alpha}1-Antitrypsin Deficiency Chest, September 1, 2003; 124(3): 826 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Yu, A. Ravelo, T. H. Wagner, C. S. Phibbs, A. Bhandari, S. Chen, and P. G. Barnett Prevalence and Costs of Chronic Conditions in the VA Health Care System Med Care Res Rev, September 1, 2003; 60(3_suppl): 146S - 167S. [Abstract] [PDF]
|
|
|
|
 |
|
 T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles, C. Murio, T. Guerrero, and R. Gisbert Costs of Chronic Bronchitis and COPD: A 1-Year Follow-up Study Chest, March 1, 2003; 123(3): 784 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hernandez, A. Casas, J. Escarrabill, J. Alonso, J. Puig-Junoy, E. Farrero, G. Vilagut, B. Collvinent, R. Rodriguez-Roisin, J. Roca, et al. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Eur. Respir. J., January 1, 2003; 21(1): 58 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Simsic, W. E. Uber, J. Lazarchick, and S. M. Bradley Systemic-to-pulmonary artery shunt thrombosis in a neonate with factor V Leiden mutation Ann. Thorac. Surg., December 1, 2002; 74(6): 2179 - 2181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N S Godtfredsen, J Vestbo, M Osler, and E Prescott Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study Thorax, November 1, 2002; 57(11): 967 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yelin, L. Trupin, M. Cisternas, M. Eisner, P. Katz, and P. Blanc A national study of medical care expenditures for respiratory conditions Eur. Respir. J., March 1, 2002; 19(3): 414 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. SIN, T. STAFINSKI, Y. C. NG, N. R. BELL, and P. JACOBS The Impact of Chronic Obstructive Pulmonary Disease on Work Loss in the United States Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 704 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Strassels, C. Chen, and D. B. Carr Postoperative Analgesia: Economics, Resource Use, and Patient Satisfaction in an Urban Teaching Hospital Anesth. Analg., January 1, 2002; 94(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Petty Oxygen in Costs of COPD Treatment Chest, October 1, 2001; 120(4): 1427 - 1427. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
